World No Tobacco Day is a good time to recall how smoking affects nearly every part of your body and causes or aggravates ...

The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and ...

New psoriasis drug Zoryve approved. How to use & why Black American participation in clinical trials is vital for health ...

Bimekizumab use for 4 years among patients with plaque psoriasis is associated with sustained efficacy outcomes and no new safety signals.

Significant interaction seen for full psoriasis polygenic risk score with waist-to-hip ratio on psoriasis risk.

Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.

The programme comprises two Phase III trials, ONWARD1 and ONWARD2, and an optional long-term extension trial, ONWARD3.

Dr. Orbai has observed that the incidence of thyroid disease is higher in women who also have another ... who have the most common type of psoriasis, plaque psoriasis, there is not a clear ...

Last December, it secured FDA approval for the treatment of adult patients with plaque psoriasis, regardless of the severity of their symptoms, making it an option for all the estimated eight ...

Since I’ve been living with psoriasis for over 15 years, you’d think I’d have this disease figured out by now. But when you live with a chronic disease, there will always be curveballs.

Patients with plaque psoriasis treated with Johnson & Johnson’s oral IL-23 inhibitor JNJ-2113 have been shown to maintain skin clearance for up to a year, pointing to a durable effect for a drug ...

For many people with psoriasis, there are bad hair days — and then there are really bad hair days, complete with itchy, flaking scalp psoriasis that can look as icky as it feels. Scalp ...